Abstract:Introduction: The tumor microenvironment (TME) has been the focus of a myriad of studies over the last decade and advancements in the field of cancer research have grown as a result. Improvements in the number of biomarkers that can be screened has increased across a variety of methods and the field of spatial profiling has largely adapted to keep pace with this. However, many challenges persist: 1) tissue microarrays can be limited by tumor heterogeneity and 2) newer technology can be cost-prohibitive. Brain tumors are of significant importance, especially those of glial origin, as they swiftly progress and result in a high fatality rate. As such, the need for more diverse therapeutic approaches is growing with many already pioneering new IHC-based strategies. The aim of this study was to address both challenges addressed above in the neurobiology space. Methods: Biomarkers of importance in brain cancer tissues were identified and three distinct panels were designed. The first panel consisted of CD68, CTLA-4, p16ink4A, p14ARF, and p53. The second included PDPN, Calretinin, MAGE-D2, PTEN, and Vimentin. The third panel included IDH2, BRAF, GFAP, VEGF, and BOP1. Staining was achieved using Bethyl Laboratories IHC-validated primary and secondary antibodies and Akoya OpalTM Polaris 7-color IHC kit fluorophores (Akoya Biosciences [NEL861001KT]). Optimization was achieved using FFPE tissue microarrays containing normal neural tissue and brain cancer subtypes. The final optimized order was then tested on whole serial sections of meningioma, astrocytoma, and glioblastoma in six-color mIF. Images were generated using the PhenoImager HT® and subsequently merged and analyzed by Pathomics. Results: Phenotyping and total cell counts for each marker were identified for each serially stained tissue set. Expression levels of MAGE-D2 and BRAF were high across malignant tissues of variable gradations. Conversely, in tissues with high expression of MAGE-D2, p53 levels in these samples were lower. This is consistent with findings that suggested that MAGE-D2 is a potential dissociator of p53 by impairing transcriptional activity. Macrophage expression appeared to correlate with CTLA4 and overall tumor infiltration. Conclusions: Utilizing several unique biomarkers to understand the spatial relationships and phenotypes within the tumor microenvironment is becoming a more common practice among researchers. In using this method of serially staining tissue sections and merging the resulting images, more researchers will have access to spatial information which may have been cost-prohibitive otherwise. Additionally, in utilizing whole sections of difficult-to-treat cancerous tissue rather than microarrays, phenotypic information is available across the entire tumor microenvironment enabling a more comprehensive assessment of the TME. Citation Format: Danielle Fails, Michael Spencer. Cyclic immunofluorescent analysis of the tumor microenvironment across human brain cancer subtypes [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6876.

Protocol to quantify immune cell distribution from the vasculature to the glioma microenvironment on sequential immunofluorescence multiplex images

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment

A highly adaptable protocol for mapping spatial features of cellular aggregates in tissues

Pipeline for Assessing Tumor Immune Status Using Superplex Immunostaining and Spatial Immune Interaction Analysis

Spatial Immunophenotyping from Whole-Slide Multiplexed Tissue Imaging Using Convolutional Neural Networks

Spatial analysis of tissue immunity and vascularity by light sheet fluorescence microscopy

Microfluidics-assisted multiplexed biomarker detection for in situ mapping of immune cells in tumor sections

Protocol to quantify the activation dynamics of tumor-associated T cells in mice by functional intravital microscopy

Spatial immunophenotyping of FFPE tissues by imaging mass cytometry

P13.04.B Dissecting high-grade glioma immune infiltration in samples from fluorescence-guided surgery: digital pathology with automated image analysis

Protocol for whole-slide image analysis of human multiplexed tumor tissues using QuPath and R

Abstract 3803: Spatial architecture of tumor and immune cell lineages in syngeneic mouse tumor tissues

Abstract 2125: Towards a spatial view of immune cell function in cancer

Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases

Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence

Abstract 3763: Comparative spatial analyses of the tumor immune landscape in different mouse models of glioblastoma

Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue

Abstract 6876: Cyclic immunofluorescent analysis of the tumor microenvironment across human brain cancer subtypes

Abstract 6878: Images to insights: Transforming TME characterization into actionable spatial metrics with AI-powered multiplex immunofluorescence

Multiplex immunofluorescence-guided laser capture microdissection for spatial transcriptomics of metastatic melanoma tissues